全文获取类型
收费全文 | 19449篇 |
免费 | 2044篇 |
国内免费 | 68篇 |
专业分类
耳鼻咽喉 | 168篇 |
儿科学 | 538篇 |
妇产科学 | 502篇 |
基础医学 | 2631篇 |
口腔科学 | 373篇 |
临床医学 | 2182篇 |
内科学 | 3975篇 |
皮肤病学 | 189篇 |
神经病学 | 2046篇 |
特种医学 | 899篇 |
外科学 | 2800篇 |
综合类 | 368篇 |
一般理论 | 14篇 |
预防医学 | 1852篇 |
眼科学 | 279篇 |
药学 | 1197篇 |
中国医学 | 6篇 |
肿瘤学 | 1542篇 |
出版年
2021年 | 263篇 |
2020年 | 167篇 |
2019年 | 273篇 |
2018年 | 305篇 |
2017年 | 236篇 |
2016年 | 265篇 |
2015年 | 291篇 |
2014年 | 397篇 |
2013年 | 676篇 |
2012年 | 858篇 |
2011年 | 936篇 |
2010年 | 504篇 |
2009年 | 564篇 |
2008年 | 823篇 |
2007年 | 899篇 |
2006年 | 848篇 |
2005年 | 921篇 |
2004年 | 842篇 |
2003年 | 788篇 |
2002年 | 767篇 |
2001年 | 626篇 |
2000年 | 648篇 |
1999年 | 606篇 |
1998年 | 281篇 |
1997年 | 244篇 |
1996年 | 255篇 |
1995年 | 213篇 |
1994年 | 241篇 |
1993年 | 204篇 |
1992年 | 435篇 |
1991年 | 425篇 |
1990年 | 417篇 |
1989年 | 460篇 |
1988年 | 375篇 |
1987年 | 380篇 |
1986年 | 359篇 |
1985年 | 327篇 |
1984年 | 267篇 |
1983年 | 217篇 |
1982年 | 174篇 |
1981年 | 151篇 |
1980年 | 135篇 |
1979年 | 212篇 |
1978年 | 176篇 |
1977年 | 143篇 |
1976年 | 143篇 |
1974年 | 176篇 |
1973年 | 139篇 |
1972年 | 152篇 |
1971年 | 139篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
992.
The authors describe a case of clinically diagnosed young onset progressive supranuclear palsy (PSP) with symptom onset at 40 years of age and no family history of neurodegenerative disease. There was no history of falls during the first year of symptoms. Genetic analysis identified this patient as having a tau exon 10 +16 mutation (MAPT, IVS10, C-U, +16). Neuropathologic examination confirmed the genetic diagnosis of frontotemporal dementia. An age at onset younger than 50 years combined with the absence of early falls may indicate the possibility of a tau mutation in clinically diagnosed PSP. 相似文献
993.
994.
995.
Tranholm M Rojkjaer R Pyke C Kristensen AT Klitgaard B Lollike K Blajchman MA 《Thrombosis research》2003,109(4):217-223
Severe thrombocytopenia is a common complication to intensive chemotherapeutic regimens. For bleeding episodes associated with severe thrombocytopenia, the current standard treatment is platelet transfusion. However, due to several transfusion complications such as transfusion-transmitted diseases, platelet refractoriness and immunomodulation, as well as increasing problems with sufficient supply of platelet products, it is imperative to search for alternatives to platelet transfusion. To test the efficacy of recombinant activated human coagulation factor VII (rFVIIa, NovoSeven) in thrombocytopenia, a preclinical study was conducted in thrombocytopenic rabbits. Thrombocytopenia was induced by a combination of gamma-irradiation and the use of platelet antibodies, and the effect of rFVIIa on nail cuticle bleeding was determined. Administration of rFVIIa at 2 mg/kg significantly shortened the prolonged bleeding time in thrombocytopenic animals (rFVIIa vs. control, median 23 min 41 s vs. 60 min, p=0.016) as well as significantly reducing the blood loss (rFVIIa vs. control, median: 8.8 vs. 12.2 nmol hemoglobin/ml, p=0.016). This effect was also reflected by a significant reduction of the prothrombin time, activated partial thromboplastin time, as well as improvement in clotting parameters in an in vitro thromboelastography thrombocytopenia model. Histopathological evaluation of kidney biopsies for the presence of micro thrombi did not reveal evidence of prothrombotic effects of rFVIIa in this model. These data demonstrate the haemostatic efficacy of rFVIIa in a rabbit model of severe thrombocytopenia. Clinical trials will be needed to further explore the potential of NovoSeven as a haemostatic agent in thrombocytopenic patients. 相似文献
996.
997.
998.
Jones G Steketee RW Black RE Bhutta ZA Morris SS;Bellagio Child Survival Study Group 《Lancet》2003,362(9377):65-71
This is the second of five papers in the child survival series. The first focused on continuing high rates of child mortality (over 10 million each year) from preventable causes: diarrhoea, pneumonia, measles, malaria, HIV/AIDS, the underlying cause of undernutrition, and a small group of causes leading to neonatal deaths. We review child survival interventions feasible for delivery at high coverage in low-income settings, and classify these as level 1 (sufficient evidence of effect), level 2 (limited evidence), or level 3 (inadequate evidence). Our results show that at least one level-1 intervention is available for preventing or treating each main cause of death among children younger than 5 years, apart from birth asphyxia, for which a level-2 intervention is available. There is also limited evidence for several other interventions. However, global coverage for most interventions is below 50%. If level 1 or 2 interventions were universally available, 63% of child deaths could be prevented. These findings show that the interventions needed to achieve the millennium development goal of reducing child mortality by two-thirds by 2015 are available, but that they are not being delivered to the mothers and children who need them. 相似文献
999.
1000.
The periocular area is a complex region with free margins and cosmetic landmarks that are easily distorted during surgical reconstruction. Repair of surgical defects should maintain both periorbital function and aesthetics. In this article we discuss the basic methods of closure (side-to-side closure, flaps, grafts and second intent healing) as they apply to the periocular area and suggest an algorhythmic approach to reconstruction by aesthetic subunit. Pertinent regional anatomy and perioperative management are also reviewed. 相似文献